Chronic meningitis by histoplasmosis: Report of a child with acute myeloid leukemia

Brazilian Journal of Infectious Diseases

Volumn 12, Issue 6, 2008, Pages 555-557

  Pereira, G H ^a,c   Padua S S ^a   Park, M V F ^a   Muller, R P ^a   Passos, R M A ^a   Menezes, Y ^b  

^a Brigadeiro Hospital   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c NONE   (Brazil)

Author keywords

Antifungal therapy; Chronic meningitis; Histoplamosis

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; MEGLUMINE ANTIMONATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B-DEOXYCHOLATE; ANTIFUNGAL AGENT; DEOXYCHOLIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ARTICLE; CASE REPORT; CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; DOSE RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRANULOMATOUS INFLAMMATION; HISTOPLASMOSIS; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; LEISHMANIASIS; MALE; MENINGITIS; SKIN BIOPSY; ACUTE DISEASE; DRUG COMBINATION; FUNGAL MENINGITIS; IMMUNE DEFICIENCY; IMMUNOLOGY; MICROBIOLOGY; MYELOID LEUKEMIA; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; AMPHOTERICIN B; ANTIFUNGAL AGENTS; CHRONIC DISEASE; DEOXYCHOLIC ACID; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FLUCONAZOLE; HISTOPLASMOSIS; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, MYELOID; MALE; MENINGITIS, FUNGAL; TREATMENT OUTCOME;

EID: 65549146733     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702008000600026     Document Type: Article

References (12)

1. Lehrnbecher T., et al. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-nstitutional clinical trial AML-BFM 93. Leukemia 2004;18(1):72-7.
2. Sung L., et al., Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia. Blood 2007;110(10):3532-9.
3. Kaspers G.J., C.M. Zwaan. Pediatric acute myeloid leukemia: towards high-quality cure of all patients. Haematologica 2007; 92(11):1519-32.
4. Zanichelli M.A. Perspectivas para a leucemia mielóide aguda na infn̂cia após a observação de um grupo de pacientes tratados convencionalmente. Rev Bras. Hematol. Hemoter 2006;28(4):246-52.
5. Chang M.R., et al., Study of 30 cases of histoplasmosis observed in the Mato Grosso do Sul State, Brazil. Rev Inst Med Trop Sao Paulo 2007;49(1):37-9.
6. Wheat L.J., et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007;45(7):807-25.
7. Fulkerson W.A., B.W. Davis. Opportunistic infections in chronic lymphocytic leukemia. South Med J 1979;72(11):1487-8.
8. Schestatsky P., et al. Isolated central nervous system histoplasmosis in immunocompetent hosts: a series of 11 cases. Scand J Infect Dis 2006;38(1):43-8.
9. Unis G., M. Oliveira F., L.C. Severo. Disseminated histoplasmosis in Rio Grande do Sul. Rev Soc Bras Med Trop 2004;37(6):463-8.
10. Wheat L.J., B.E. Batteiger, B. Sathapatayavongs. Histoplasma capsulatum infections of the central nervous system. A clinical review. Medicine (Baltimore). 1990;69(4):244-60.
11. Odio C.M., et al. Disseminated histoplasmosis in infants. Pediatr Infect Dis J 1999;18(12):1065-8.
12. Wheat L.J., C.E. Musial, E. Jenny-Avital. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis 2005; 40(6):844-52.